α-Tocopheryl phosphate - An active lipid mediator?

Molecular Nutrition and Food Research

Volumn 54, Issue 5, 2010, Pages 679-692

  Zingg, Jean Marc ^a   Meydani, Mohsen ^a   Azzi, Angelo ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

EPC k1; Kinase; Phospholipids; Tocopherol; Tocopheryl phosphate

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL PHOSPHATE; ALPHA-TOCOPHEROL PHOSPHATE; ANTIOXIDANT; DRUG DERIVATIVE; ENZYME; LIPID; PHOSPHATASE; PHOSPHOLIPID; PHOSPHOTRANSFERASE;

BLOOD; DRUG EFFECT; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ALPHA-TOCOPHEROL; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; ENZYMES; HUMANS; LIPIDS; PHOSPHOLIPIDS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PHOSPHOTRANSFERASES;

ANIMALIA;

EID: 77952405282     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900404     Document Type: Review

References (186)

1. Evans, H. M., Bishop, K. S., On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922, 56, 650-651.
2. Ingold, K. U., Bowry, V. W., Stocker, R., Walling, C., Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc. Natl. Acad. Sci. USA 1993, 90, 45-49.
3. Niki, E., Interaction of ascorbate and alpha-tocopherol. Ann. NY Acad. Sci. 1987, 498, 186-199.
4. Smith, D., O'Leary, V. J., Darley-Usmar, V. M., The role of alpha-tocopherol as a peroxyl radical scavenger in human low density lipoprotein. Biochem. Pharmacol. 1993, 45, 2195-2201.
5. Zingg, J. M., Azzi, A., Non-antioxidant activities of vitamin E. Cur. Med. Chem. 2004, 11, 1113-1133.
6. Brigelius-Flohe, R., Vitamin E: the shrew waiting to be tamed. Free Radic. Biol. Med. 2009, 46, 543-554.
7. Ricciarelli, R., Zingg, J. M., Azzi, A., Vitamin E: protective role of a Janus molecule. FASEB J. 2001, 15, 2314-2325.
8. Brigelius-Flohe, R., Kelly, F. J., Salonen, J. T., Neuzil, J. et al., The European perspective on vitamin E: current knowledge and future research. Am. J. Clin. Nutr. 2002, 76, 703-716.
9. Rimbach, G., Minihane, A. M., Majewicz, J., Fischer, A. et al., Regulation of cell signalling by vitamin E. Proc. Nutr. Soc. 2002, 61, 415-425.
10. Zingg, J. M., Modulation of signal transduction by vitamin E. Mol. Aspects Med. 2007, 28, 481-506.
11. Zingg, J. M., Molecular and cellular activities of vitamin E analogues. Mini Rev. Med. Chem. 2007, 7, 543-558.
12. Wu, J. H., Croft, K. D., Vitamin E metabolism. Mol. Aspects Med. 2007, 28, 437-452.
13. Muller, D. P., Manning, J. A., Mathias, P. M., Harries, J. T., Studies on the intestinal hydrolysis of tocopheryl esters. Int. J. Vitam. Nutr. Res. 1976, 46, 207-210.
14. Mathias, P. M., Harries, J. T., Peters, T. J., Muller, D. P., Studies on the in vivo absorption of micellar solutions of tocopherol and tocopheryl acetate in the rat: demonstration and partial characterization of a mucosal esterase localized to the endoplasmic reticulum of the enterocyte. J. Lipid Res. 1981, 22, 829-837.
15. Horwitt, M. K., Elliott, W. H., Kanjananggulpan, P., Fitch, C. D., Serum concentrations of alpha-tocopherol after ingestion of various vitamin E preparations. Am. J. Clin. Nutr. 1984, 40, 240-245.
16. Nierenberg, D. W., Lester, D. C., Colacchio, T. A., Determination of tocopherol and tocopherol acetate concentrations in human feces using high-performance liquid chromatography. J. Chromatogr. 1987, 413, 79-89.
17. Lauridsen, C., Hedemann, M. S., Jensen, S. K., Hydrolysis of tocopheryl and retinyl esters by porcine carboxyl ester hydrolase is affected by their carboxylate moiety and bile acids. J. Nutr. Biochem. 2001, 12, 219-224.
18. Zhukova, E. E., Zakharova, E. I., Sokolova, N. A., Sarycheva, I. K., Evstigneeva, R. P., Esters of DL-alpha-tocopherol and phosphoric acid, Plenum Publishing Corporation, 1084.
19. Ogru, E., Gianello, R., Libinaki, R., Smallridge, A. et al. (Eds.), Vitamin E Phosphate: An Endogenous Form of Vitamin E, Medimond S.r.l., Bologna, 2003.
20. Gianello, R., Libinaki, R., Azzi, A., Gavin, P. D. et al., Alphatocopheryl phosphate: a novel, natural form of vitamin E. Free Radic. Biol. Med. 2005, 39, 970-976.
21. Negis, Y., Zingg, J. M., Ogru, E., Gianello, R. et al., On the existence of cellular tocopheryl phosphate, its synthesis, degradation and cellular roles: a hypothesis. IUBMB Life 2005,57,23-25. &2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
22. Libinaki, R., Ogru, E., Gianello, R., Bolton, L., Geytenbeek, S., Evaluation of the safety of mixed tocopheryl phosphates (MTP)-A formulation of alpha-tocopheryl phosphate plus alpha-di-tocopheryl phosphate. Food Chem. Toxicol. 2005, 44, 916-932.
23. Gianello, R., Hall, W. C., Kennepohl, E., Libinaki, R., Ogru, E., Subchronic oral toxicity study of mixed tocopheryl phosphates in rats. Int. J. Toxicol. 2007, 26, 475-490.
24. Negis, Y., Aytan, N., Ozer, N., Ogru, E. et al., The effect of tocopheryl phosphates on atherosclerosis progression in rabbits fed with a high cholesterol diet. Arch. Biochem. Biophys. 2006, 450, 63-66.
25. Rigotti, A., Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects Med. 2007, 28, 423-436.
26. Brisson, L., Castan, S., Fontbonne, H., Nicoletti, C. et al., Alpha-tocopheryl acetate is absorbed and hydrolyzed by Caco-2 cells comparative studies with alpha-tocopherol. Chem. Phys. Lipids 2008, 154, 33-37.
27. Kagan, V. E., Bakalova, R. A., Serbinova, E. E., Stoytchev, T. S., Fluorescence measurements of incorporation and hydrolysis of tocopherol and tocopheryl esters in biomembranes. Methods Enzymol. 1990, 186, 355-367.
28. Nakayama, S., Katoh, E. M., Tsuzuki, T., Kobayashi, S., Protective effect of alpha-tocopherol-6-O-phosphate against ultraviolet B-induced damage in cultured mouse skin. J. Invest. Dermatol. 2003, 121, 406-411.
29. Negis, Y., Meydani, M., Zingg, J. M., Azzi, A., Molecular mechanism of alpha-tocopheryl-phosphate transport across the cell membrane. Biochem. Biophys. Res. Commun. 2007, 359, 348-353.
30. Tanaka, Y., Moritoh, Y., Miwa, N., Age-dependent telomere-shortening is repressed by phosphorylated alpha- tocopherol together with cellular longevity and intracellular oxidative-stress reduction in human brain micro- vascular endotheliocytes. J. Cell Biochem. 2007, 102, 689-703.
31. Fariss, M., Anionic Tocopherol Esters as Antioxidants and Cytoprotectants, Marcel Dekker, New York 1997.
32. Zingg, J. M., Azzi, A., Meydani, M., Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr. Rev. 2008, 66, 406-414.
33. Oram, J. F., Vaughan, A. M., Stocker, R., ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J. Biol. Chem. 2001, 276, 39898-39902.
34. Mustacich, D. J., Leonard, S. W., Devereaux, M. W., Sokol, R. J., Traber, M. G., Alpha-tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Radic. Biol. Med. 2006, 41, 1069-1078.
35. Frikke-Schmidt, R., Nordestgaard, B. G., Jensen, G. B., Steffensen, R., Tybjaerg-Hansen, A., Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 180-186.
36. Mustacich, D. J., Shields, J., Horton, R. A., Brown, M. K., Reed, D. J., Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. Arch. Biochem. Biophys. 1998, 350, 183-192.
37. Doring, F., Rimbach, G., Lodge, J. K., In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life 2004, 56, 615-620.
38. Traber, M. G., Kayden, H. J., Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein. Am. J. Clin. Nutr. 1984, 40, 747-751.
39. Borel, P., Moussa, M., Reboul, E., Lyan, B. et al., Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J. Nutr. 2007, 137, 2653-2659.
40. Pascoe, G. A., Reed, D. J., Relationship between cellular calcium and vitamin E metabolism during protection against cell injury. Arch. Biochem. Biophys. 1987, 253, 287-296.
41. Anwar, K., Iqbal, J., Hussain, M. M., Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J. Lipid Res. 2007, 48, 2028-2038.
42. Voegele, A. F., Jerkovic, L., Wellenzohn, B., Eller, P. et al., Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry 2002, 41, 14532-14538.
43. Kostner, G. M., Oettl, K., Jauhiainen, M., Ehnholm, C. et al., Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem. J. 1995, 305, 659-667.
44. Jiang, X. C., Tall, A. R., Qin, S., Lin, M. et al., Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J. Biol. Chem. 2002, 277, 31850-31856.
45. Narushima, K., Takada, T., Yamanashi, Y., Suzuki, H., Niemann-pick C1-like 1 mediates alpha-tocopherol transport. Mol. Pharmacol. 2008, 74, 42-49.
46. Hentati, A., Deng, H. X., Hung, W. Y., Nayer, M. et al., Human alpha-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency. Ann. Neurol. 1996, 39, 295-300.
47. Zimmer, S., Stocker, A., Sarbolouki, M. N., Spycher, S. E. et al., A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J. Biol. Chem. 2000, 275, 25672-25680.
48. Kempna, P., Zingg, J. M., Ricciarelli, R., Hierl, M. et al., Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties. Free Radic. Biol. Med. 2003, 34, 1458-1472.
49. Ni, J., Wen, X., Yao, J., Chang, H. C. et al., Tocopherol- associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res. 2005, 65, 9807-9816.
50. Neuzil, J., Dong, L. F., Wang, X. F., Zingg, J. M., Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. Biochem. Biophys. Res. Commun. 2006, 343, 1113-1117.
51. Zingg, J. M., Kempna, P., Paris, M., Reiter, E. et al., Characterization of three human sec14p-like proteins: alpha- tocopherol transport activity and expression pattern in tissues. Biochimie 2008, 90, 1703-1715.
52. Kaempf-Rotzoll, D. E., Traber, M. G., Arai, H., Vitamin E and transfer proteins. Curr. Opin. Lipidol. 2003, 14, 249-254.
53. Mousley, C. J., Tyeryar, K. R., Vincent-Pope, P., Bankaitis, V. A., The Sec14-superfamily and the regulatory interface between phospholipid metabolism and membrane trafficking. Biochim. Biophys. Acta 2007, 1771, 727-736.
54. Bankaitis, V. A., Vincent, P., Merkulova, M., Tyeryar, K., Liu, Y., Phosphatidylinositol transfer proteins and functional specification of lipid signaling pools. Adv. Enzyme Regul. 2007,47,27-40.
55. Saito, K., Tautz, L., Mustelin, T., The lipid-binding SEC14 domain. Biochim. Biophys. Acta 2007, 1771, 719-726.
56. Caras, I. W., Friedlander, E. J., Bloch, K., Interactions of supernatant protein factor with components of the microsomal squalene epoxidase system. Binding of supernatant protein factor to anionic phospholipids. J. Biol. Chem. 1980,255,3575-3580.
57. Merkulova, M. I., Andreeva, S. G., Shuvaeva, T. M., Novoselov, S. V. et al., A novel 45 kDa secretory protein from rat olfactory epithelium: primary structure and localisation. FEBS Lett. 1999, 450, 126-130.
58. Shibata, N., Arita, M., Misaki, Y., Dohmae, N. et al., Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis. Proc. Natl. Acad. Sci. USA 2001, 98, 2244-2249.
59. Kempna, P., Cipollone, R., Villacorta, L., Ricciarelli, R., Zingg, J. M., Isoelectric point mobility shift assay for rapid screening of charged and uncharged ligands bound to proteins. IUBMB Life 2003, 55, 103-107.
60. Panagabko, C., Morley, S., Hernandez, M., Cassolato, P. et al., Ligand specificity in the CRAL-TRIO protein family. Biochemistry 2003, 42, 6467-6474.
61. Merkulova, M., Huynh, H., Radchenko, V., Saito, K. et al., Secretion of the mammalian Sec14p-like phosphoinositide-binding p45 protein. FEBS J. 2005, 272, 5595-5605.
62. Habermehl, D., Kempna, P., Azzi, A., Zingg, J. M., Recombinant SEC14-like proteins (TAP) possess GTPase activity. Biochem. Biophys. Res. Commun. 2005, 326, 254-259.
63. Zingg, J. M., Azzi, A., Comment re: Vitamin E transport gene variants and prostate cancer. Cancer Res. 2009, 69, 6756; author reply 6756.
64. Shiau, C. W., Huang, J. W., Wang, D. S., Weng, J. R. et al., Alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of BCL-XL/BCL-2 function. J. Biol. Chem. 2006, 281, 11819-11825.
65. Neuzil, J., Dyason, J. C., Freeman, R., Dong, L. F. et al., Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J. Bioenerg. Biomembr. 2007, 39, 65-72.
66. Dong, L. F., Low, P., Dyason, J. C., Wang, X. F. et al., Alpha- tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008, 27, 4324-4335.
67. Mokashi, V., Singh, D. K., Porter, T. D., Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro. Arch. Biochem. Biophys. 2005, 433, 474-480.
68. Shibata, N., Jishage, K., Arita, M., Watanabe, M. et al., Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis. FASEB J. 2006, 20, 2642-2644.
69. Cummings, M. J., Mattill, H. A., The auto-oxidation of fats with reference to their destructive effect on vitamin E. J. Nutr. 1931, 3, 421-432.
70. Hickman, K. C. D., Harris, P. L. (Eds.), Tocopherol Interrelationships, Interscience Publisher Inc., New York 1946.
71. Milhorat, A. T., Bartels, W. E., The defect in utilization of tocopherol in progressive muscular dystrophy. Science 1945,101,93-94.
72. Suarna, C., Wu, B. J., Choy, K., Mori, T. et al., Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic. Biol. Med. 2006, 41, 722-730.
73. Roberts, L. J., II, Oates, J. A., Linton, M. F., Fazio, S. et al., The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic. Biol. Med. 2007,43,1388-1393.
74. Brigelius-Flohe, R., Kluth, D., Banning, A., Is there a future for antioxidants in atherogenesis? Mol. Nutr. Food Res. 2005,49,1083-1089.
75. Zingg, J. M., Azzi, A., in: Meskin, M. S., Bidlack, W. R., Randoph, R. K. (Eds.), Phytochemicals: Nutrient-Gene Interactions, Taylor & Francis, Boca Raton 2006, pp. 175-206.
76. Rezk, B. M., Haenen, G. R., Van Der Vijgh, W. J., Bast, A., The extraordinary antioxidant activity of vitamin E phosphate. Biochim. Biophys. Acta 2004, 1683, 16-21.
77. Masaki, H., Okano, Y., Ochiai, Y., Obayashi, K. et al., Alpha- tocopherol increases the intracellular glutathione level in HaCaT keratinocytes. Free Radic. Res. 2002, 36, 705-709.
78. Sampayo-Reyes, A., Zakharyan, R. A., Tocopherol esters inhibit human glutathione S-transferase omega. Acta Biochim. Pol. 2006, 53, 547-552.
79. Ames, S. R., Effect of calcium on the inhibition of the succinic oxidase system by d-alpha-tocopheryl phosphate. J. Biol. Chem. 1947, 503, 503-512.
80. Nason, A., Lehman, I. R., Tocopherol as an activator of cytochrome C reductase. Science 1955, 122, 19-22.
81. Govier, W. M., Jetter, N. S., The effect of agr-tocopheryl phosphate on diphosphopyridine nucleotidase. Science 1948,107,146-147.
82. Eppstein, S. H., Morgulis, S., Factors influencing the onset and cure of nutritional muscular dystrophy. J. Nutr. 1941, 23,473-482.
83. Hove, E. L., Harris, P. L., Relative activity of the tocopherols in curing muscular dystrophy in rabbits. J. Nutr. 1947, 33, 95-106.
84. Houchin, O. B., The in vitro effect of alpha-tocopherol and its phosphate derivative on oxidation in muscle tissue. J. Biol. Chem. 1942, 146, 313-321.
85. Houchin, O. B., Mattill, H. A., The influence of parenteral administration of alpha-tocopherol phosphate on the metabolic process in dystrophic muscle. J. Biol. Chem. 1942,146,309-312.
86. Rabinovitz, M., Boyer, P. D., The inhbition of the succinoxidase system by alpha-tocopheryl phosphate and sodium dodecyl sulfate. J. Biol. Chem. 1949, 111-121.
87. Detwiler, T. C., Garrett, R. H., Nason, A., Effects of digitonin and tocopherol on bovine heart muscle reduced diphosphopyridine nucleotide- and succinate-cytochrome c reductase and cytochrome c oxidase. J. Biol. Chem. 1966, 241,1621-1631.
88. Sakai, T., Okano, T., Makino, H., Tsudzuki, T., Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative. J. Cyclic Nucleotide Res. 1976, 2, 163-170.
89. Abita, J. P., Parniak, M., Kaufman, S., The activation of rat liver phenylalanine hydroxylase by limited proteolysis, lysolecithin, and tocopherol phosphate. Changes in conformation and catalytic properties. J. Biol. Chem. 1984, 259,14560-14566.
90. Scott, P. M., Chemical studies concerning the possible role of chromanyl phosphates and quinones in oxidative phosphorylation. J. Biol. Chem. 1965, 240, 1374-1380.
91. Ricciarelli, R., Zingg, J. M., Azzi, A., Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000, 102, 82-87.
92. Munteanu, A., Zingg, J. M., Ogru, E., Libinaki, R. et al., Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem. Biophys. Res. Commun. 2004, 318,311-316.
93. Munteanu, A., Ricciarelli, R., Massone, S., Zingg, J. M., Modulation of proteasome activity by vitamin E in THP-1 monocytes. IUBMB Life 2007, 59, 771-780.
94. Navarro, A., Gomez, C., Sanchez-Pino, M. J., Gonzalez, H. et al., Vitamin E at high doses improves survival, neurological performance and brain mitochondrial function in aging male mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R1392-R1399.
95. Selman, C., McLaren, J. S., Mayer, C., Duncan, J. S. et al., Lifelong alpha-tocopherol supplementation increases the median life span of C57BL/6 mice in the cold but has only minor effects on oxidative damage. Rejuvenation Res. 2008,11,83-96.
96. Rezk, B. M., van der Vijgh, W. J., Bast, A., Haenen, G. R., Alpha-tocopheryl phosphate is a novel apoptotic agent. Front. Biosci. 2007, 12, 2013-2019.
97. de Jesus Ferreira, M. C., Crouzin, N., Barbanel, G., Cohen-Solal, C. et al., A transient treatment of hippocampal neurons with alpha-tocopherol induces a long-lasting protection against oxidative damage via a genomic action. Free Radic. Biol. Med. 2005, 39, 1009-1020.
98. Crouzin, N., de Jesus Ferreira, M. C., Cohen-Solal, C., Aimar, R. F. et al., Alpha-tocopherol-mediated long-lasting protection against oxidative damage involves an attenuation of calcium entry through TRP-like channels in cultured hippocampal neurons. Free Radic. Biol. Med. 2007, 42, 1326-1337.
99. Dyatlov, V. A., Makovetskaia, V. V., Leonhardt, R., Lawrence, D. A., Carpenter, D. O., Vitamin E enhances Ca(21)- mediated vulnerability of immature cerebellar granule cells to ischemia. Free Radic. Biol. Med. 1998, 25, 793-802.
100. Chaumontet, C., Bex, V., Veran, F., Martel, P., The vitamin E analog tocopherol succinate strongly inhibits gap junctional intercellular communication in rat liver epithelial cells (IAR203). J. Nutr. Biochem. 2008, 19, 263-268.
101. Zierler, K. L., Grob, D., Lilienthal, J. L., Jr., On the antithrombic and antiproteolytic activity of alpha tocopheryl phosphate. Am. J. Physiol. 1948, 153, 127-132.
102. Violi, F., Micheletta, F., Iuliano, L., Vitamin E, atherosclerosis and thrombosis. Thromb. Haemost. 2001, 85, 766-770.
103. Zierler, K. L., Folk, B. P., Lilienthal, J. L., Jr., On the mechanism of action of alpha-tocopheryl phosphate, with special reference to carbohydrate metabolism of striated muscle. I. Modification of epinephrine effect, hyperlactacidemia, by alpha-tocopheryl phosphate in the rat. Bull. Johns Hopkins Hosp. 1953, 92, 26-30.
104. Zierler, K. L., Andres, R., Levy, R. I., Anderson, H. M., Lilienthal, J. L., Jr., On the mechanism of action of alpha- tocopheryl phosphate, with special reference to carbohydrate metabolism of striated muscle. II. Effect on the capacity of rat diaphragm to dissimilate hexose phosphates. Bull. Johns Hopkins Hosp. 1953, 92, 32-39.
105. Zierler, K. L., Levy, R. I., Lilienthal, J. L., Jr., On the mechanism of action of alpha-tocopheryl phosphate, with special reference to carbohydrate metabolism of striated muscle. III. Inhibition of insulin-induced glycogenesis in isolated rat diaphragm. Bull. Johns Hopkins Hosp. 1953, 92,41-46.
106. Quaife, M. L., Fat-soluble vitamins. Annu. Rev. Biochem. 1954,23,215-244.
107. Xie, Z., Sastry, B. R., Induction of hippocampal long-term potentiation by alpha-tocopherol. Brain Res. 1993, 604, 173-179.
108. Ito, S., Mori, T., Kanazawa, H., Sawaguchi, T., Differential effects of the ascorbyl and tocopheryl derivative on the methamphetamine-induced toxic behavior and toxicity. Toxicology 2007, 240, 96-110.
109. Giarman, N. J., Bowers, G. N., Jr., Quie, P. G., Hampton, L. J., Potentiation of certain barbiturates by alpha-tocopherol phosphate. Arch. Int. Pharmacodyn. Ther. 1954, 97, 473-482.
110. Mirsky, J. H., Giarman, N. J., Studies on the potentiation of thiopental. J. Pharmacol. Exp. Ther. 1955, 114, 240-249.
111. Mukherjee, S., Lekli, I., Das, M., Azzi, A., Das, D. K., Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim. Biophys. Acta 2008, 1782, 498-503.
112. Dragsted, L. O., Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers. Eur. J. Nutr. 2008, 47, 3-18.
113. Meydani, M., Koga, T., Ali, S., Encyclopedia of Life Sciences, Nature Publishing Group, Hoboken 2001, pp. 1-6.
114. Yokota, T., Igarashi, K., Uchihara, T., Jishage, K. et al., Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. USA 2001,98,15185-15190.
115. Cuddihy, S. L., Ali, S. S., Musiek, E. S., Lucero, J. et al., Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in the brain. J. Biol. Chem. 2008, 283, 6915-6924.
116. Moore, T., Fat-soluble vitamins. Annu. Rev. Biochem. 1950,19,319-338.
117. Zingg, J. M., Vitamin E: an overview of major research directions. Mol. Aspects Med. 2007, 28, 400-422.
118. Traber, M. G., Atkinson, J., Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 2007, 43, 4-15.
119. Azzi, A., Molecular mechanism of alpha-tocopherol action. Free Radic. Biol. Med. 2007, 43, 16-21.
120. Infante, J. P., Vitamin E and selenium participation in fatty acid desaturation. A proposal for an enzymatic function of these nutrients. Mol. Cell Biochem. 1986, 69, 93-108.
121. Infante, J. P., A function for the vitamin E metabolite alpha-tocopherol quinone as an essential enzyme cofactor for the mitochondrial fatty acid desaturases. FEBS Lett. 1999,446,1-5.
122. Winkler, W., Nahvi, A., Breaker, R. R., Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 2002, 419, 952-956.
123. Spiegel, S., Milstien, S., Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 2002, 277, 25851-25854.
124. Xu, Y., Seet, L. F., Hanson, B., Hong, W., The Phox homology (PX) domain, a new player in phosphoinositide signalling. Biochem. J. 2001, 360, 513-530.
125. Kempna, P., Reiter, E., Arock, M., Azzi, A., Zingg, J. M., Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. J. Biol. Chem. 2004, 279, 50700-50709.
126. Atkinson, J., Epand, R. F., Epand, R. M., Tocopherols and tocotrienols in membranes: a critical review. Free Radic. Biol. Med. 2008, 44, 739-764.
127. Royer, M. C., Lemaire-Ewing, S., Desrumaux, C., Monier, S. et al., 7-Ketocholesterol incorporation into sphingolipid/ cholesterol-enriched (lipid raft) domains is impaired by vitamin E: a specific role for alpha-tocopherol with consequences on cell death. J. Biol. Chem. 2009, 284, 15826-15834.
128. Cuschieri, J., Bulger, E., Biligren, J., Garcia, I., Maier, R. V., Vitamin E inhibits endotoxin-mediated transport of phosphatases to lipid rafts. Shock 2007, 27, 19-24.
129. Konorev, E. A., Saks, V. A., Rudnev, D. V., Konorev, L. A. et al., [Phosphocreatine, tocopheryl phosphate and their combination in acute ischemia and myocardial reperfusion in dogs: the effect on rhythm disorders, left ventricle contractility and infarct size]. Vestn. Akad. Med. Nauk. SSSR 1991, 35-39.
130. Donapaty, S., Louis, S., Horvath, E., Kun, J. et al., RRR- alpha-tocopherol succinate down-regulates oncogenic Ras signaling. Mol. Cancer Ther. 2006, 5, 309-316.
131. Huang, P. H., Wang, D., Chuang, H. C., Wei, S. et al., Alpha- Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis. Carcinogenesis 2009, 30, 1125-1131.
132. Uto-Kondo, H., Ohmori, R., Kiyose, C., Kishimoto, Y. et al., Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadipocytes. J. Nutr. 2009, 139,51-57.
133. Numakawa, Y., Numakawa, T., Matsumoto, T., Yagasaki, Y. et al., Vitamin E protected cultured cortical neurons from oxidative stress-induced cell death through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J. Neurochem. 2006, 97, 1191-1202.
134. Vejux, A., Guyot, S., Montange, T., Riedinger, J. M. et al., Phospholipidosis and down-regulation of the PI3-K/PDK-1/ Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J. Nutr. Biochem. 2009, 20, 45-61.
135. Munteanu, A., Taddei, M., Tamburini, I., Bergamini, E. et al., Antagonistic effects of oxidized low density lipo- protein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: Involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 2006, 281, 6489-6497.
136. Lee, H. J., Ju, J., Paul, S., So, J. Y. et al., Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma. Clin. Cancer Res. 2009,15,4242-4249.
137. Zhang, B., Tanaka, J., Yang, L., Sakanaka, M. et al., Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience 2004, 126, 433-440.
138. Ou, B., Huang, D., Hampsch-Woodill, M., Flanagan, J. A., When east meets west: the relationship between yin-yang and antioxidation-oxidation. FASEB J. 2003, 17, 127-129.
139. Lopez-Carballo, G., Moreno, L., Masia, S., Perez, P., Barettino, D., Activation of the phosphatidylinositol 3-kinase/ Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 2002, 277, 25297-25304.
140. Wang, P., Yu, W., Hu, Z., Jia, L. et al., Involvement of JNK/ p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol. Carcinog. 2008, 47, 436-445.
141. Malafa, M. P., Fokum, F. D., Andoh, J., Neitzel, L. T. et al., Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis. Int. J. Cancer 2006, 118, 2441-2447.
142. Gills, J. J., Dennis, P. A., The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/ threonine kinase, Akt. Expert Opin. Investig. Drugs 2004, 13,787-797. & 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
143. Moses, S. A., Ali, M. A., Zuohe, S., Du-Cuny, L. et al., In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT. Cancer Res. 2009, 69, 5073-5081.
144. Rajendran, L., Schneider, A., Schlechtingen, G., Weidlich, S. et al., Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science 2008, 320, 520-523.
145. Little, P. J., Ballinger, M. L., Survase, S., Osman, N. et al., Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis. J. Cardiovasc. Pharmacol. 2008, 51,274-279.
146. Wei, T., Chen, C., Li, F., Zhao, B. et al., Antioxidant properties of EPC-K1: a study on mechanisms. Biophys. Chem. 1999,77,153-160.
147. Zhang, W. R., Hayashi, T., Sasaki, C., Sato, K. et al., Attenuation of oxidative DNA damage with a novel antioxidant EPC- K1 in rat brain neuronal cells after transient middle cerebral artery occlusion. Neurol. Res. 2001, 23, 676-680.
148. Tomita, T., Kashima, M., Tsujimoto, Y., Characterization of the activity of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl- hydrogen phosphate] potassium salt in hydroxyl radical elimination. Chem. Pharm. Bull. (Tokyo) 2000, 48, 330-333.
149. Kozuka, M., Tsujimoto, Y., Dentin is dissolved by high concentrations of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8- tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzo pyran- 6-yl-hydrogen phosphate] potassium salt with or without hydrogen peroxide. Biol. Pharm. Bull. 2004, 27, 831-834.
150. Munteanu, A., Zingg, J. M., Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol. Aspects Med. 2007, 28, 538-590.
151. Wei, T., Chen, C., Hou, J., Zhao, B. et al., The antioxidant EPC-K1 attenuates NO-induced mitochondrial dysfunction, lipid peroxidation and apoptosis in cerebellar granule cells. Toxicology 1999, 134, 117-126.
152. Okamoto, K., Tanaka, H., Makino, Y., Makino, I., Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2- (4,8,12-trimethyltridecyl)-2H-1-benzo pyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem. Pharmacol. 1998, 56, 79-86.
153. Hirano, F., Tanaka, H., Miura, T., Hirano, Y. et al., Inhibition of NF-kappaB-dependent transcription of human immunodeficiency virus 1 promoter by a phosphodiester compound of vitamin C and vitamin E, EPC-K1. Immunopharmacology 1998, 39, 31-38.
154. Takayama, H., Hamner, C. E., Caccitolo, J. A., Hisamochi, K. et al., A novel antioxidant, EPC-K1, stimulates endothelial nitric oxide production and scavenges hydroxyl radicals. Circ. J. 2003, 67, 1046-1052.
155. Kabuto, H., Yokoi, I., Iwata-Ichikawa, E., Ogawa, N., EPC- K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity. Neurochem. Res. 1999, 24, 1543-1548.
156. Chan, A. C., Partners in defense, vitamin E and vitamin C. Can. J. Physiol. Pharmacol. 1993, 71, 725-731.
157. May, J. M., Is ascorbic acid an antioxidant for the plasma membrane? FASEB J. 1999, 13, 995-1006.
158. Antoniades, C., Tousoulis, D., Tentolouris, C., Toutouzas, P., Stefanadis, C., Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz 2003, 28, 628-638.
159. Abudu, N., Miller, J. J., Attaelmannan, M., Levinson, S. S., Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin. Chim. Acta 2004, 339, 11-25.
160. Kuribayashi, Y., Katori, M., Majima, M., Yoshida, K., Inhibitory effects of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) on myocardial infarction in rats. Int. J. Tissue React. 1996, 18, 73-79.
161. Hisamochi, K., Morimoto, T., Bando, K., Senoo, Y., Teramoto, S., A new hydroxyl radical scavenger ''EPC'' on cadaver heart transplantation in a canine model. Surg. Today 1997, 27, 930-935.
162. Mundy, A. L., Haas, E., Bhattacharya, I., Widmer, C. C. et al., Endothelin stimulates vascular hydroxyl radical formation: effect of obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293, R2218-R2224.
163. Ohba, M., Hori, Y., Kadowaki, E., Takamatsu, T., Matsuoka, M., [Stability studies on L-ascorbic acid dl-alpha-tocopherol phosphoric acid diester potassium salt (EPC-K)]. Yakugaku Zasshi 1994, 114, 514-522.
164. Bogaert, E., Van Damme, P., Van Den Bosch, L., Robberecht, W., Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle Nerve 2006, 34, 391-405.
165. Lambrechts, D., Carmeliet, P., VEGF at the neuro- vascular interface: therapeutic implications for motor neuron disease. Biochim. Biophys. Acta 2006, 1762, 1109-1121.
166. Li, B., Xu, W., Luo, C., Gozal, D., Liu, R., VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1- mediated motor neuron cell death. Brain Res. Mol. Brain Res. 2003, 111, 155-164.
167. Carey, M. M., Dziewiatkowski, D. D., The adenosine- triphosphatase and phosphatase (acid and alkaline) activity of muscle homogenates from rabbits on a vitamin E-deficient diet. J. Biol. Chem. 1949, 179, 119-131.
168. Narindrasorasak, S., Tan, L. U., Seth, P. K., Sanwal, B. D., Regulation of cyclic adenosine 30:50-monophosphate phosphodiesterases. Interrelationship of the various forms in rat skeletal myoblasts and adult muscle. J. Biol. Chem. 1982,257,4618-4626.
169. Jacobi, H. P., Chappell, J. W., Morgulis, S., Effect of alpha- tocopheryl phosphate on enzyme activity. Arch. Biochem. 1950,27,22-28.
170. Jacobi, H. P., Rosenblatt, S., Chappell, J. W., Morgulis, S., The locus of action of alpha-tocopheryl phosphate in the succinoxidase system. Arch. Biochem. 1950, 27, 9-18.
171. Govier, W. M., Yanz, N., Grelis, M. E., The effect of alpha tocopherol phosphate, digitoxin and certain compounds related to the latter on cardiac muscle metabolism in vitro. J. Pharmacol. Exp. Ther. 1946, 88, 373-381.
172. Brase, D. A., Westfall, T. C., Stimulation of rat liver phenylalanine hydroxylase activity by derivatives of vitamin E. Biochem. Biophys. Res. Commun. 1972, 48, 1185-1191.
173. Kihara, A., Mitsutake, S., Mizutani, Y., Igarashi, Y., Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1- phosphate. Prog. Lipid Res. 2007, 46, 126-144.
174. Carman, G. M., Han, G. S., Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem. Sci. 2006, 31, 694-699.
175. Bentinger, M., Grunler, J., Peterson, E., Swiezewska, E., Dallner, G., Phosphorylation of farnesol in rat liver microsomes: properties of farnesol kinase and farnesyl phosphate kinase. Arch. Biochem. Biophys. 1998, 353, 191-198.
176. Das, S., Schapira, M., Tomic-Canic, M., Goyanka, R. et al., Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors. Mol. Endocrinol. 2007, 21, 2672-2686.
177. Liliom, K., Tsukahara, T., Tsukahara, R., Zelman-Femiak, M. et al., Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs. Biochim. Biophys. Acta 2006, 1761,1506-1514.
178. Enayetallah, A. E., Grant, D. F., Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis. Biochem. Biophys. Res. Commun. 2006, 341,254-260.
179. Li, M. H., Sanchez, T., Pappalardo, A., Lynch, K. R. et al., Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1- phosphate receptor 2. Mol. Cancer Res. 2008, 6, 1649-1656.
180. Zhou, Y., Suram, A., Venugopal, C., Prakasam, A. et al., Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP- CTFgamma. FASEB J. 2008, 22, 47-54.
181. Elliott, G. T., Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J. Mol. Cell Cardiol. 1998, 30, 3-17.
182. Herdendorf, T. J., Miziorko, H. M., Phosphomevalonate kinase: functional investigation of the recombinant human enzyme. Biochemistry 2006, 45, 3235-3242.
183. Michell, R. H., Inositol derivatives: evolution and functions. Nat. Rev. Mol. Cell Biol. 2008, 9, 151-161.
184. Fukunaga, K., Arita, M., Takahashi, M., Morris, A. J. et al., Identification and functional characterization of a presqualene diphosphate phosphatase. J. Biol. Chem. 2006,281,9490-9497.
185. Carlo, T., Petasis, N., Levy, B., Activation of polyisoprenyl diphosphate phosphatase 1 remodels cellular presqualene diphosphate. Biochemistry 2009.
186. Dallner, G., Brismar, K., Chojnacki, T., Swiezewska, E., Regulation of coenzyme Q biosynthesis and breakdown. Biofactors 2003, 18, 11-22.